Connection

Thomas Hanff to Prospective Studies

Back to Details
This is a "connection" page, showing publications Thomas Hanff has written about Prospective Studies.
Thomas Hanff
Connection Strength
0.018
Prospective Studies
  1. Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. Lancet Respir Med. 2021 03; 9(3):275-284.
    View in: PubMed
    Score: 0.009
  2. Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol. J Clin Hypertens (Greenwich). 2020 10; 22(10):1780-1788.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.